Overview

A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness and tolerability of MK8141 in lowering blood pressure in patients who have hypertension (high blood pressure).
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Collaborator:
Actelion
Treatments:
Enalapril
Enalaprilat